Read by QxMD icon Read

Journal of ECT

Raphael J Braga, Majnu John, Nina R Schooler, Samuel H Bailine, Chitra Malur, Alan Mendelowitz, Georgios Petrides
OBJECTIVES: The risk of relapse after a successful acute course of treatment is a clinical challenge in electroconvulsive therapy (ECT) practice, particularly in patients with a history of marked resistance to previous treatments. Research suggests that a gradual decrease of ECT or its long-term continuation might be the best strategy. Notwithstanding, current studies do not address the role of continuation ECT in the truly refractory cases, that is, the clozapine-resistant patients. Our group published a randomized controlled trial of ECT augmentation of clozapine in clozapine-resistant patients with schizophrenia, where the augmentation was vastly superior in efficacy for the acute treatment...
April 9, 2019: Journal of ECT
Patricia Paparone, Pei-Lee Ee, Charles H Kellner
No abstract text is available yet for this article.
April 9, 2019: Journal of ECT
Jessie Hanna, Periel Shapiro, Ariana Gover-Chamlou, Emily Komarczyk
No abstract text is available yet for this article.
April 8, 2019: Journal of ECT
Naveen Thomas, Miranda Sollychin, Anna Takács, Fiona Connally, Alby Elias, Christos Pantelis
No abstract text is available yet for this article.
April 8, 2019: Journal of ECT
Damian A Almiron Bonnin, Paul E Holtzheimer, Julia Knight
No abstract text is available yet for this article.
April 8, 2019: Journal of ECT
Yarong Ma, Robert Rosenheck, Ni Fan, Hongbo He
OBJECTIVE: Recent studies have expressed concern about the infrequent and declining use of electroconvulsive therapy (ECT) in the United States. However, it is not known whether the US experience reflects changing global practice or one that varies between countries. This observational study examined use of ECT in the largest psychiatric hospital in China's third largest city over a 4-year period, 2014 to 2017. METHODS: Unduplicated electronic medical records concerning all inpatients with psychiatric diagnoses were examined...
March 25, 2019: Journal of ECT
Didde Bjørnshauge, Simon Hjerrild, Poul Videbech
OBJECTIVES: The aim of this study was to survey and describe the contemporary practice of electroconvulsive therapy (ECT) in the Kingdom of Denmark (Denmark, Greenland, and the Faroe Islands). METHODS: Data regarding number of ECTs and number of patients with different diagnoses treated with ECT were retrieved from the Danish National Patient Registry. In addition, a 45-item questionnaire was sent to all psychiatric departments practicing ECT in Denmark (n = 26), Greenland (n = 1), and the Faroe Islands (n = 1)...
March 25, 2019: Journal of ECT
Akihiro Takamiya, Kyosuke Sawada, Jinichi Hirano, Masaru Mimura, Taishiro Kishimoto
No abstract text is available yet for this article.
March 13, 2019: Journal of ECT
Rikinkumar S Patel, Shailesh Bobby Jain, Nagy A Youssef
OBJECTIVE: Main objectives of the study are to (1) describe the utilization of electroconvulsive treatment (ECT) for the treatment of manic episodes (ME) and (2) examine the effect of early inpatient use of ECT (within 7 days of admission) compared with delayed use on length of stay and cost of inpatient care. METHOD: The total sample of 14,005 inpatients with a principal diagnosis of bipolar disorder, ME (2012-2014), from the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project were analyzed using univariate and logistic regressions...
March 13, 2019: Journal of ECT
Worrawat Chanpattana, William V McCall
This commentary reflects upon the study of Braga et al of open-label continuation electroconvulsive therapy (ECT) plus clozapine in treatment-resistant schizophrenia (TRS), as reported in this issue of The Journal of ECT. The evidence base for ECT in TRS is scant, and the study of Braga et al is a step forward. However, their report raises other important questions including (1) what is the proper frequency of continuation ECT in TRS, and (2) should TRS patients, even TRS patients who have failed clozapine, receive acute ECT + clozapine, or is ECT + conventional antipsychotics sufficient? In this commentary, we examine these questions and outline a future research strategy for TRS that includes large simple trials...
March 13, 2019: Journal of ECT
Partha Das, Karuppiah Jagadheesan, Frances Walker, Vinay Lakra, Nicola T Lautenschlager, Angelo Ferraro, Devapriya Rudolph
OBJECTIVES: The main objective of our study was to examine whether there has been any change to electroconvulsive therapy (ECT) practice since the new Mental Health Act 2014 (MHA) in a public metropolitan mental health service in Victoria. METHODS: This retrospective study examined any change in ECT rate following the new MHA. We compared sociodemographic, clinical, and ECT-related variables for patients treated before (July 1, 2013, and June 30, 2014) and after (1st July 2014 and the 30th June 2015) the new MHA...
March 13, 2019: Journal of ECT
Giovanni Martinotti, Matteo Lupi, Chiara Montemitro, Andrea Miuli, Chiara Di Natale, Maria Chiara Spano, Valerio Mancini, Marco Lorusso, Gianfranco Stigliano, Antonio Tambelli, Francesco Di Carlo, Lucia Di Caprio, Silvia Fraticelli, Eleonora Chillemi, Mauro Pettorruso, Gianna Sepede, Massimo di Giannantonio
OBJECTIVES: The use of transcranial direct current stimulation (tDCS) in addiction disorders is still on its rise in comparison with pharmacological and psychotherapeutic strategies that still show low level of evidence. In this study, we aimed to evaluate the efficacy of the anodic tDCS for the short-term treatment of substance craving and other psychiatric symptoms. METHODS: In this randomized, double-blind, sham-controlled trial, inclusion criteria included the diagnosis of substance use disorder and/or gambling disorder...
March 5, 2019: Journal of ECT
Eveline M Veltman, Alef de Boer, Annemiek Dols, Eric van Exel, Max L Stek, Pascal Sienaert, Filip Bouckaert, Roos van der Mast, Didi Rhebergen
OBJECTIVES: In clinical practice, particularly melancholic depression benefits from electroconvulsive therapy (ECT), albeit research melancholia criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM) is not conclusive. We compared clinical characteristics and ECT outcome of melancholic and nonmelancholic depression, here defined by psychomotor symptoms. METHODS: One hundred ten depressed older in-patients treated with ECT were included in the Mood Disorders in Elderly treated with ECT study...
March 5, 2019: Journal of ECT
Elisabetta Maffioletti, Massimo Gennarelli, Giulio Gainelli, Luisella Bocchio-Chiavetto, Marco Bortolomasi, Alessandra Minelli
OBJECTIVES: Electroconvulsive therapy (ECT) represents one of the most effective therapies for treatment-resistant depression (TRD). The brain-derived neurotrophic factor (BDNF) is a neurotrophin implicated in major depressive disorder and in the effects of different therapeutic approaches, including ECT. Both BDNF peripheral levels and Val66Met polymorphism have been suggested as biomarkers of treatment effectiveness. The objective of this study was to test the potential of serum BDNF levels and Val66Met polymorphism in predicting ECT outcome in TRD patients...
February 26, 2019: Journal of ECT
Ida Rönnqvist, Ole Brus, Åsa Hammar, Mikael Landén, Johan Lundberg, Pia Nordanskog, Axel Nordenskjöld
OBJECTIVES: Electroconvulsive therapy (ECT) is used in some cases of postpartum depression (PPD) and postpartum psychosis (PPP). The risk of relapse for PPD and PPP after ECT is unknown. This study compared the relapse rate after ECT between women who had been treated for PPD and/or PPP and women who had been treated for depression and/or psychosis outside the postpartum period. METHODS: The Swedish National Quality Register for ECT and the Swedish National Patient Register were used to identify women with PPD and/or PPP who had been treated with ECT within 6 months after delivery...
February 20, 2019: Journal of ECT
Ahmed Naguy, Ali Al-Tajali, Bibi Alamiri
No abstract text is available yet for this article.
February 16, 2019: Journal of ECT
Charles H Kellner, Navjot Brainch, Camila Albuquerque
No abstract text is available yet for this article.
February 16, 2019: Journal of ECT
Gwynedd E Pickett, Lara Hazelton
No abstract text is available yet for this article.
February 1, 2019: Journal of ECT
Joseph J Cooper, Khalid I Afzal
No abstract text is available yet for this article.
February 1, 2019: Journal of ECT
Lysandre Delamarre, Filipe Galvao, Bénédicte Gohier, Emmanuel Poulet, Jerome Brunelin
BACKGROUND: Electroconvulsive therapy (ECT) is one of the most effective treatments for major depressive disorder (MDD), especially in cases of treatment-resistant MDD. Because of their pharmacological profiles, benzodiazepines (BZDs) are suspected to decrease the efficacy of ECT. This study investigated the effect of BZDs on ECT-induced clinical outcomes and ECT course parameters in patients with MDD. METHOD: The impact of BZDs on severity of depression (Montgomery-Asberg Depression Rating Scale scores) and on ECT course parameters (seizure threshold, clinical and electroencephalographic seizure duration) was investigated in 70 patients with MDD who received an ECT course using dose-titration method (22 received concomitant BZDs)...
February 1, 2019: Journal of ECT
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"